Overview
The Evolving Role of Nutrition Therapy in the Hospitalized Patient: Focus on Lipids and Protein
Malnutrition Roundtable Discussion
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
Despite recognition of underfeeding in hospital settings and its consequences, a substantial number of hospitalized patients can be characterized as malnourished. In this roundtable discussion, Canadian and US-based faculty discuss diagnostic criteria for malnutrition, available and emerging lipid emulsion products and their influence on inflammation and ensuring adequate protein delivery for optimal nutrition support.
This activity is intended for physicians, pharmacists, nurses and dietitians who manage clinical nutrition.
New research has provided evidence of the complexity of a patient’s nutritional needs during hospitalization. As our understanding of nutrition in hospitalized patients expands, the importance of tailoring nutritional therapies to the individual becomes more apparent. Further, new and emerging products for lipid emulsion and protein delivery are available. Updating clinicians on the many recent changes to nutritional therapy in the hospital is essential to aid patients in achieving their nutritional goals.
Upon completion of this activity, participants will be able to:
• Explain new standard diagnostic criteria for malnutrition outlined by the Global Leadership Initiative on Malnutrition (GLIM) and how it applies to clinical practice
• Interpret available outcome data on new lipid emulsion products and how the differences in fatty acid profiles of new products may influence inflammation
• Discuss how high vs. standard protein delivery may benefit hospitalized patients, particularly in the ICU
• Compare and contrast newly available and emerging macronutrient parenteral nutrition products, and describe how these new products can aid in improving nutrition therapy for hospitalized patients
• Explain new standard diagnostic criteria for malnutrition outlined by the Global Leadership Initiative on Malnutrition (GLIM) and how it applies to clinical practice
• Interpret available outcome data on new lipid emulsion products and how the differences in fatty acid profiles of new products may influence inflammation
• Discuss how high vs. standard protein delivery may benefit hospitalized patients, particularly in the ICU
• Compare and contrast newly available and emerging macronutrient parenteral nutrition products, and describe how these new products can aid in improving nutrition therapy for hospitalized patients
Sponsored by the Academy for Continued Healthcare Learning (ACHL).
Supported by an educational grant from Baxter Healthcare Corporation.
Johane P. Allard, MD, FRCPC
Professor of Medicine
Department of Medicine, Gastroenterology
University of Toronto
Toronto General Hospital
Toronto, Ontario, Canada
Professor of Medicine
Department of Medicine, Gastroenterology
University of Toronto
Toronto General Hospital
Toronto, Ontario, Canada
Manpreet S. Mundi, MD
Associate Professor of Medicine
Medical Director, Home Enteral Nutrition Program
Mayo Clinic College of Medicine and Science
Rochester, Minnesota
Juan B. Ochoa Gautier, MD, FACS
Professor of Surgery
Ochsner Health System
New Orleans, Louisiana
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.
The following financial relationships have been provided:
Manpreet Mundi, MD
Research Support: Fresenius Kabi, Nestle Heath Science, Real Food Blends
The following faculty have no relevant financial relationships to disclose:
Johane Allard, MD, FRCP
Juan Ochoa Gautier, MD, FACS
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Parenteral nutrition products available outside the United States.
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 45 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 80% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact Katlyn Cooper at kcooper@achlcme.org
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse practitioners may participate in this educational activity and earn a certificate of completing as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.
The Academy for Continued Healthcare Learning is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 1.0 Continuing Professional Education units (CPEUs) for completion of this activities/materials. Level 2. CDR Accredited Provider #AC001.
RDs and DTRs may submit additional evaluations of the quality of this program/material at www.cdrnet.org.
The activity number for this activity is 151733.
Completion of this activity including the pre and/or post assignments qualifies as a medium weight MIPS improvement activity under MACRA and can be claimed as completion of IA_PSPA 28 of an Accredited Safety or Quality Improvement Program in the Quality Payment Program. Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website. You will receive additional information after completing the activity and receiving your certificate via email.
